Istent Infinite Clinical Data Glaukos In the 12 month pivotal trial, exceptional intraoperative and postoperative safety was demonstrated among patients with 2 or more failed filtering surgeries. Prospective, multicenter, single arm study of the istent infinite in adult pseudophakic or phakic subjects with mild to moderate primary open angle glaucoma who have not failed conventional medical and surgical treatment.
Istent Infinite Clinical Data Glaukos Purpose: the purpose of this study is to evaluate safety and effectiveness of the istent infinite trabecular micro bypass system in patients with oag uncontrolled by prior surgical or medical therapy. design: prospective, multicenter, single arm, open label clinical trial. The purpose of this study is to evaluate safety and effectiveness of the istent infinite trabecular micro bypass system in patients with oag uncontrolled by prior surgical or medical therapy. Today, patients in need of standalone glaucoma surgery have limited micro invasive options to treat their condition. istent infinite addresses that gap in the treatment algorithm. In the prospective, multicenter, 12 month pivotal trial, patients with open angle glaucoma who had failed prior surgical intervention underwent standalone istent infinite ® implantation 1.
Istent Infinite Clinical Data Glaukos Today, patients in need of standalone glaucoma surgery have limited micro invasive options to treat their condition. istent infinite addresses that gap in the treatment algorithm. In the prospective, multicenter, 12 month pivotal trial, patients with open angle glaucoma who had failed prior surgical intervention underwent standalone istent infinite ® implantation 1. Dr. iqbal ike k. ahmed presents groundbreaking data on the newly approved istent infinite, demonstrating remarkable reductions in intraocular pressure and medication use among challenging to treat glaucoma patients. This was a prospective, randomized, double masked, multicenter, 24 month study to compare effectiveness and safety outcomes following standalone implantation of two types of current generation trabecular stents in adults with open angle glaucoma. The istent infinite ® demonstrated exceptional intra and postoperative safety. in the trial, there were no cases of hypotony, no explants, no cyclodialysis clefts, and no device related interventions. A prospective, randomized, controlled, comparitive multicenter clinical study of glaukos® trabecular micro bypass system model is3 infinite® vs competitor in adult subjects with primary open angle glaucoma (poag).
Comments are closed.